Caixin
Apr 30, 2022 08:00 AM

Qingdao Haier Biomedical Co.,Ltd.’s Net Profit Dropped 72.9% in First Quarter of 2022

Qingdao Haier Biomedical Co.,Ltd. (青岛海尔生物医疗股份有限公司) (688139.SH) reported a net profit of 113.9 million yuan in the first quarter of 2022, down 72.9% year-on-year.

Meanwhile, the company posted 563.5 million yuan in revenue, up 36.2% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 25%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST